Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRUE
4176
DELISTED
TrueCar
TRUE
| $159K | ﹤0.01% |
61,642
+26,646
| +76% | +$68.4K |
|
4177
Tenaris
TS
$26.7B
| $159K | ﹤0.01% |
12,249
-6,387
| -34% | -$84.4K |
|
|
PFNX
4178
DELISTED
Pfenex Inc.
PFNX
| $159K | ﹤0.01% |
18,976
+8,874
| +88% | +$66.4K |
|
4179
PUT
Radware
RDWR
$1.17B
| $158K | ﹤0.01% |
6,700
-8,500
| -56% | -$195K |
|
4180
CALL
Yeti Holdings
YETI
$3.99B
| $158K | ﹤0.01% |
3,700
-15,300
| -81% | -$460K |
|
|
PVLA
4181
Palvella Therapeutics
PVLA
$2.21B
| $158K | ﹤0.01% |
637
+149
| +31% | +$34.8K |
|
|
ANH
4182
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $158K | ﹤0.01% |
92,571
+21,377
| +30% | +$33.2K |
|
4183
Costamare
CMRE
$1.81B
| $157K | ﹤0.01% |
28,159
+10,997
| +64% | +$53.6K |
|
4184
Dyadic International
DYAI
$36.4M
| $157K | ﹤0.01% |
+18,150
| New | +$121K |
|
4185
Lands' End
LE
$397M
| $157K | ﹤0.01% |
19,521
+13,610
| +230% | +$97.9K |
|
4186
Team
TISI
$77.5M
| $157K | ﹤0.01% |
2,809
+321
| +13% | +$17.7K |
|
|
LORL
4187
DELISTED
Loral Space and Communications, Inc.
LORL
| $157K | ﹤0.01% |
8,068
+1,082
| +15% | +$20.3K |
|
4188
CALL
Alaska Air
ALK
$5.7B
| $156K | ﹤0.01% |
4,300
-16,700
| -80% | -$544K |
|
4189
Aquestive Therapeutics
AQST
$481M
| $156K | ﹤0.01% |
+32,342
| New | +$149K |
|
4190
PUT
PTC
PTC
$15.5B
| $156K | ﹤0.01% |
2,000
-3,000
| -60% | -$213K |
|
|
CNCE
4191
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $156K | ﹤0.01% |
15,745
+7,043
| +81% | +$67.5K |
|
4192
Century Casinos
CNTY
$32.9M
| $155K | ﹤0.01% |
37,431
-43,338
| -54% | -$182K |
|
4193
PUT
NovaGold Resources
NG
$3.01B
| $155K | ﹤0.01% |
16,900
-24,400
| -59% | -$247K |
|
4194
PUT
NETGEAR
NTGR
$650M
| $155K | ﹤0.01% |
6,000
-200
| -3% | -$4.87K |
|
|
STR
4195
DELISTED
Sitio Royalties
STR
| $155K | ﹤0.01% |
12,062
+4,700
| +64% | +$49.4K |
|
4196
West Bancorporation
WTBA
$482M
| $155K | ﹤0.01% |
8,869
+3,553
| +67% | +$61.3K |
|
4197
PUT
Zimmer Biomet
ZBH
$18.7B
| $155K | ﹤0.01% |
1,339
-74,984
| -98% | -$8.64M |
|
|
CIM
4198
PUT
Chimera Investment
CIM
$995M
| $153K | ﹤0.01% |
5,300
-309,867
| -98% | -$7.96M |
|
4199
FRP Holdings
FRPH
$411M
| $153K | ﹤0.01% |
7,578
+2,936
| +63% | +$60.8K |
|
|
SY
4200
So-Young International
SY
$205M
| $153K | ﹤0.01% |
+11,300
| New | +$119K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.